{"id":"https://openalex.org/W2479018367","doi":"https://doi.org/10.1007/s12185-016-2073-4","title":"Cereblon and its downstream substrates as molecular targets of immunomodulatory drugs","display_name":"Cereblon and its downstream substrates as molecular targets of immunomodulatory drugs","publication_year":2016,"publication_date":"2016-07-26","ids":{"openalex":"https://openalex.org/W2479018367","doi":"https://doi.org/10.1007/s12185-016-2073-4","mag":"2479018367","pmid":"https://pubmed.ncbi.nlm.nih.gov/27460676"},"language":"en","primary_location":{"id":"doi:10.1007/s12185-016-2073-4","doi":"https://doi.org/10.1007/s12185-016-2073-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12185-016-2073-4","pdf_url":"https://link.springer.com/content/pdf/10.1007%2Fs12185-016-2073-4.pdf","source":{"id":"https://openalex.org/S45192162","display_name":"International Journal of Hematology","issn_l":"0925-5710","issn":["0925-5710","1865-3774"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Hematology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://link.springer.com/content/pdf/10.1007%2Fs12185-016-2073-4.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010700890","display_name":"Takumi Ito","orcid":"https://orcid.org/0000-0002-9997-2664","observed_orcids":["https://orcid.org/0000-0002-9997-2664"]},"institutions":[{"id":"https://openalex.org/I158929114","display_name":"Tokyo Medical University","ror":"https://ror.org/00k5j5c86","country_code":"JP","type":"education","lineage":["https://openalex.org/I158929114"]},{"id":"https://openalex.org/I4210086780","display_name":"Japan Science and Technology Agency","ror":"https://ror.org/00097mb19","country_code":"JP","type":"government","lineage":["https://openalex.org/I1319490839","https://openalex.org/I4210086780"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takumi Ito","raw_affiliation_strings":["Department of Nanoparticle Translational Research, Tokyo Medical University, 6-1-1, Shinjuku, Shinjuku-ku, Tokyo, 160-8402, Japan","PRESTO, JST, 4-1-8, Honcho, Kawaguchi, Saitama, 332-0012, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nanoparticle Translational Research, Tokyo Medical University, 6-1-1, Shinjuku, Shinjuku-ku, Tokyo, 160-8402, Japan","institution_ids":["https://openalex.org/I158929114"]},{"raw_affiliation_string":"PRESTO, JST, 4-1-8, Honcho, Kawaguchi, Saitama, 332-0012, Japan","institution_ids":["https://openalex.org/I4210086780"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034882455","display_name":"Hiroshi Handa","orcid":"https://orcid.org/0000-0001-6656-9521","observed_orcids":["https://orcid.org/0000-0001-6656-9521","https://orcid.org/0000-0003-3753-9862"]},"institutions":[{"id":"https://openalex.org/I158929114","display_name":"Tokyo Medical University","ror":"https://ror.org/00k5j5c86","country_code":"JP","type":"education","lineage":["https://openalex.org/I158929114"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Hiroshi Handa","raw_affiliation_strings":["Department of Nanoparticle Translational Research, Tokyo Medical University, 6-1-1, Shinjuku, Shinjuku-ku, Tokyo, 160-8402, Japan. hhanda@tokyo-med.ac.jp","Department of Nanoparticle Translational Research, Tokyo Medical University, 6-1-1, Shinjuku, Shinjuku-ku, Tokyo, 160-8402, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nanoparticle Translational Research, Tokyo Medical University, 6-1-1, Shinjuku, Shinjuku-ku, Tokyo, 160-8402, Japan. hhanda@tokyo-med.ac.jp","institution_ids":["https://openalex.org/I158929114"]},{"raw_affiliation_string":"Department of Nanoparticle Translational Research, Tokyo Medical University, 6-1-1, Shinjuku, Shinjuku-ku, Tokyo, 160-8402, Japan","institution_ids":["https://openalex.org/I158929114"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5034882455"],"corresponding_institution_ids":["https://openalex.org/I158929114"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":0.9239,"has_fulltext":true,"cited_by_count":87,"citation_normalized_percentile":{"value":0.68924442,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"104","issue":"3","first_page":"293","last_page":"299"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9657999873161316,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9657999873161316,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.016599999740719795,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.008700000122189522,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cereblon","display_name":"cereblon","score":0.9769999980926514},{"id":"https://openalex.org/keywords/immunomodulators","display_name":"immunomodulators","score":0.9639999866485596},{"id":"https://openalex.org/keywords/thalidomide","display_name":"thalidomide","score":0.9629999995231628},{"id":"https://openalex.org/keywords/crl4-e3-ubiquitin-ligase","display_name":"CRL4 E3 ubiquitin ligase","score":0.9850000143051147},{"id":"https://openalex.org/keywords/ikaros","display_name":"Ikaros","score":0.7310000061988831},{"id":"https://openalex.org/keywords/aiolos","display_name":"Aiolos","score":0.9990000128746033},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.7239999771118164},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.546999990940094},{"id":"https://openalex.org/keywords/protein-degradation","display_name":"protein degradation","score":0.703000009059906},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.6100000143051147},{"id":"https://openalex.org/keywords/drug-target-identification","display_name":"drug target identification","score":0.4569999873638153}],"concepts":[{"id":"https://openalex.org/C2778540781","wikidata":"https://www.wikidata.org/wiki/Q21112029","display_name":"Cereblon","level":5,"score":0.991945743560791},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.8869009017944336},{"id":"https://openalex.org/C134459356","wikidata":"https://www.wikidata.org/wiki/Q4274835","display_name":"Ubiquitin ligase","level":4,"score":0.7149684429168701},{"id":"https://openalex.org/C2778524551","wikidata":"https://www.wikidata.org/wiki/Q7227206","display_name":"Pomalidomide","level":4,"score":0.5360199809074402},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.5273633599281311},{"id":"https://openalex.org/C25602115","wikidata":"https://www.wikidata.org/wiki/Q407111","display_name":"Ubiquitin","level":3,"score":0.5196745991706848},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.47986167669296265},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45412248373031616},{"id":"https://openalex.org/C2908868211","wikidata":"https://www.wikidata.org/wiki/Q4274835","display_name":"Ubiquitin-Protein Ligases","level":5,"score":0.4473516047000885},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4152519702911377},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40914011001586914},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3444744646549225},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3348585367202759},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33099281787872314},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.21889936923980713},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12595659494400024},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010447","descriptor_name":"Peptide Hydrolases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013379","descriptor_name":"Substrate Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044767","descriptor_name":"Ubiquitin-Protein Ligases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D048868","descriptor_name":"Adaptor Proteins, Signal Transducing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/s12185-016-2073-4","doi":"https://doi.org/10.1007/s12185-016-2073-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12185-016-2073-4","pdf_url":"https://link.springer.com/content/pdf/10.1007%2Fs12185-016-2073-4.pdf","source":{"id":"https://openalex.org/S45192162","display_name":"International Journal of Hematology","issn_l":"0925-5710","issn":["0925-5710","1865-3774"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Hematology","raw_type":"journal-article"},{"id":"pmid:27460676","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27460676","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of hematology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s12185-016-2073-4","doi":"https://doi.org/10.1007/s12185-016-2073-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12185-016-2073-4","pdf_url":"https://link.springer.com/content/pdf/10.1007%2Fs12185-016-2073-4.pdf","source":{"id":"https://openalex.org/S45192162","display_name":"International Journal of Hematology","issn_l":"0925-5710","issn":["0925-5710","1865-3774"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Hematology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7684226432","display_name":"Elucidation of the molecular mechanism of the anti-cancer activity of IMiDs","funder_award_id":"26750374","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2479018367.pdf","grobid_xml":"https://content.openalex.org/works/W2479018367.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W1527383154","https://openalex.org/W1537559901","https://openalex.org/W1565539350","https://openalex.org/W1597238753","https://openalex.org/W1628369270","https://openalex.org/W1970400561","https://openalex.org/W1973999018","https://openalex.org/W1977046091","https://openalex.org/W1981403111","https://openalex.org/W1982855701","https://openalex.org/W1985147506","https://openalex.org/W1985585046","https://openalex.org/W1987995025","https://openalex.org/W1997952190","https://openalex.org/W2005505584","https://openalex.org/W2015345028","https://openalex.org/W2025656486","https://openalex.org/W2033556677","https://openalex.org/W2034031119","https://openalex.org/W2050723187","https://openalex.org/W2053925177","https://openalex.org/W2065718044","https://openalex.org/W2066713758","https://openalex.org/W2068412287","https://openalex.org/W2077848703","https://openalex.org/W2083492838","https://openalex.org/W2084778320","https://openalex.org/W2114492363","https://openalex.org/W2124938253","https://openalex.org/W2128338459","https://openalex.org/W2129129812","https://openalex.org/W2131256397","https://openalex.org/W2142031342","https://openalex.org/W2143261659","https://openalex.org/W2161413435","https://openalex.org/W2161767400","https://openalex.org/W2161904562","https://openalex.org/W2162559503","https://openalex.org/W2176682109","https://openalex.org/W2299508065","https://openalex.org/W2316160054","https://openalex.org/W2336461395","https://openalex.org/W2470671857","https://openalex.org/W4211136726","https://openalex.org/W4234293563"],"related_works":["https://openalex.org/W2496065064","https://openalex.org/W2621834981","https://openalex.org/W64963360","https://openalex.org/W4284887817","https://openalex.org/W2038890080","https://openalex.org/W7099048603","https://openalex.org/W2412947633","https://openalex.org/W2949174139","https://openalex.org/W3214572735","https://openalex.org/W2115859409"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-08-23T00:00:00"}